BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion
In-Young Jung(University of Pennsylvania), Joseph A. Fraietta(University of Pennsylvania)
Cited by 126
Related Papers
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
|American Journal of Hematology|2019|608
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
|Nature Medicine|2024|254
FOXO1 is a master regulator of memory programming in CAR T cells
|Nature|2024|189